American MSO Cannabis Stocks Continued Upward This Week
As reported last week, the U.S. Department of Health & Human Services has recommended to the Drug Enforcement Administration that they reclassify marijuana's drug status to that of a Schedule III (i.e. lower-risk) substance based on a recent Food and Drug Administration review. If implemented it would substantially ease banking requirements for MSO companies, allow major U.S. stock exchanges to list MSOs on their exchanges and potentially allow foreign companies to begin selling their products in the United States.
Investors responded enthusiastically a week ago to the recommendation with a 39% jump in the industry's average stock price by week's end ( (and a 44% increase in the average stock price of the industry's 7 largest multi-state operators ( MSOs) as tracked in munKNEE's American Cannabis MSO Index). and the upward trend has continued this week up another 22% (and by 20% in the American Cannabis MSO Index).
Below are the changes in the stock prices of the 7 constituents in the Index this week in descending order of performance, last week and YTD:
- Columbia Care (CCHWF): UP 53.3% this week; UP 82.9% last week; UP 53.3% YTD
- Cresco Labs (CRLBF): UP 47.6% this week; UP 50.1% last week; UP 40.0% YTD
- Verano Holdings (VRNOF): UP 30.7% this week; UP 30.7% last week; UP 59.1% YTD
- Curaleaf Holdings (CURLF): UP 21.6% this week; UP 32.4% last week; UP 22.5% YTD
- Green Thumb (GTBIF): UP 12.6% this week; UP 39.7% last week; UP 26.9% YTD
- Trulieve Cannabis (TCNNF): UP 11.6% this week; UP 63.3% last week; DOWN 14.7% YTD
- TerrAscend Corp. (TSNDF): UP 7.9% this week; UP 25.5% last week; UP 98.2% YTD
Conclusion
The average increase in our American Cannabis MSO Index this week was 19.5%.
More By This Author:
U.S. Cannabis Stocks Continue Upwards This Week - Here's Why
Now Is The Time To Bet On AI - Here's Why; Here's Where; Here's How
6 Largest Psychedelic Compound-Based R & D Stocks Up 4%, On Average, Last Week
Disclosure: None
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more